Fernandes Henrique Veiga
Fondatore presso LiMM Therapeutics SA
Profilo
Fernandes Henrique Veiga is the founder of LiMM Therapeutics SA. He is currently working as the Chief Scientific Officer at StemCell2MAX.
Posizioni attive di Fernandes Henrique Veiga
| Società | Posizione | Inizio |
|---|---|---|
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Fondatore | - |
StemCell2MAX
 StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
StemCell2MAX
StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | Commercial Services |
- Borsa valori
- Insiders
- Fernandes Henrique Veiga